A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growthQing-yong Hu, Yang Cao, Yu-huang Li et al.|Acta Pharmacologica Sinica|2024Cited by 5